Home Cart Sign in  
Chemical Structure| 2364554-48-1 Chemical Structure| 2364554-48-1

Structure of Aficamten
CAS No.: 2364554-48-1

Chemical Structure| 2364554-48-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aficamten is a cardiac myosin allosteric inhibitor.

Synonyms: CK-274; CK-3773274

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Aficamten

CAS No. :2364554-48-1
Formula : C18H19N5O2
M.W : 337.38
SMILES Code : O=C(C1=CN(C)N=C1)N[C@H]2C3=CC=C(C4=NOC(CC)=N4)C=C3CC2
Synonyms :
CK-274; CK-3773274
MDL No. :MFCD34602690

Safety of Aficamten

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Aficamten

cytoskeleton

Isoform Comparison

Biological Activity

Description
Aficamten (CK-274) is a potent cardiac myosin inhibitor with an IC50 of 1.4 μM, suitable for researching hypertrophic cardiomyopathy (HCM) [1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06116968 Obstructive Hypertrophic Cardi... More >>omyopathy Less << PHASE3 RECRUITING 2026-03-15 Beijing Anzhen Hospital, Beiji... More >>ng, China|Beijing Chao-yang Hospital, Capital Medical University, Beijing, China|Fuwai Hospital, CAMS & PUMC, Beijing, China|Peking University Third Hospital, Beijing, China|Sichuan Provincial People's Hospital, Chengdu, China|Nanfang Hospital, Guangzhou, China|The Second Affiliated Hospital of Nanchang University, Jiangxi, China|The First Hospital of Jilin University, Jilin, China|Shengjing Hospital of China Medical University, Shenyang, China|Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.82mL

2.96mL

1.48mL

29.64mL

5.93mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories